Skip to content

Adjunctive Oral Probiotics in Endodontic Retreatment: Effects on Postoperative Pain and RANKL/OPG Levels

The Effect of Systemic Administration of Probiotics and Intra-Canal Medications on Level of Nuclear Factor Kappa B Ligand, Osteoprotegerin and Postoperative Pain in Patients With Chronic Apical Periodontitis: (Randomized Controlled Clinical Trial)

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07683520
Acronym
RANKL/OPG
Enrollment
72
Registered
2026-07-06
Start date
2025-10-04
Completion date
2026-06-20
Last updated
2026-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Apical Periodontitis

Keywords

RANKL, OPG, Probiotics, Ca(OH)2, Propolis, Postoperative pain, retreatment

Brief summary

This study aimed to evaluate the effect of oral administration of probiotics as an adjunctive treatment to local intracanal medicaments, namely propolis and calcium hydroxide or empty canal, on the levels of receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG), as well as on postoperative pain following root canal retreatment of teeth with chronic apical periodontitis

Detailed description

Post-treatment chronic apical periodontitis is an inflammatory condition caused by persistent microbial infection within the root canal system, characterized by progressive periapical bone destruction mediated by host immune-inflammatory mechanisms. Root canal retreatment remains the treatment of choice for failed endodontic cases; however, postoperative pain and incomplete resolution of inflammatory mediators remain common concerns. Clinical evidence demonstrates that postoperative pain following endodontic retreatment is influenced by microbial persistence, host inflammatory response, and intracanal medication protocols. The RANK/RANKL/OPG axis is a key regulator of osteoclastic activity and periapical bone resorption. Elevated RANKL levels and altered RANKL/OPG ratio are associated with active periapical bone destruction. Modulation of this pathway may improve healing outcomes. Recent studies suggest that probiotics can regulate immune response, reduce inflammatory cytokines, and decrease RANKL expression. This randomized clinical trial includes patients diagnosed with previously root-filled teeth presenting with chronic apical periodontitis indicated for non-surgical retreatment. Standardized retreatment procedures are performed under aseptic conditions. Periapical exudate samples collected for biochemical analysis of RANKL and OPG levels at predetermined time points. Postoperative pain is assessed to investigate whether systemic probiotic administration can act as a host-modulating adjunct in endodontic retreatment and improve both symptomatic and biological healing outcomes.

Interventions

DIETARY_SUPPLEMENTLinex Adult®

Linex Adult® is an oral probiotic formulation containing Lactobacillus acidophilus, Bifidobacterium animalis, It is administered as one capsule once daily for 21 days.

Intracanal medication kept for 21 days

OTHERPlacebo

Placebo capsule for 21 days

DRUGpropolis intracanal medication

Intracanal medication kept for 21 days

OTHEREmpty canal

Empty canal for 21 days

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Masking was implemented at the participant and outcomes assessor levels. Randomization and allocation concealment were performed by an independent person not involved in treatment procedures or outcome assessment. For systemic probiotic, the probiotic and placebo capsules were prepared in identical opaque containers, and the allocation key was maintained by the independent allocator until completion of data collection. so, the principal investigator and care provider were blinded regarding probiotic/placebo allocation throughout the intervention period. However, due to the nature of the intracanal medicament intervention (calcium hydroxide or propolis or left empty ), blinding of the principal investigator and care provider was not feasible at the stage of ICM placement. But allocation concealment for the intracanal medicament was maintained using sealed opaque envelopes, which were opened only after completion of all treatment procedures and immediately before placement of the ICM

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Previously treated failed single rooted teeth with chronic apical periodontitis. * No use of antibiotic three months before treatment. * Patients are free of any systemic disease. * Positive patient acceptance for participation

Exclusion criteria

* Teeth that are badly broken down with difficult isolation. * Signs of acute infection, root fracture, root surface caries, swellings or ankylosis * Periodontally affected teeth with pockets deeper than 4mm. * Pregnant or lactating woman. * Patients who needs any prophylactic antibiotic. * Patients with allergy to pollen.

Design outcomes

Primary

MeasureTime frameDescription
The effect on RANKL and OPG levels in teeth with chronic apical periodontitis.(S1) measured in the first visit Immediately post-instrumentation and before ICM placement or oral supplement administration. (S2) After 21 days, immediately after removal of ICM and before obturation.Level of RANKL and OPG measured with periapical samples (S1) and (S2) and analysed using ELISA test

Secondary

MeasureTime frameDescription
The effect on postoperative pain.Inter-appointment pain: baseline (start of the first visit), 4, 12, 24, 48, and 72 hours, and Week 1 and Week 2 after the first visit. Post-obturation pain: baseline (start of the second visit), 4, 12, 24, 48, and 72 hours after obturation.Pain level measured using the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst possible pain), to evaluate inter-appointment pain between the first and second retreatment visits and post-obturation pain after the second retreatment visit and root canal obturation.

Countries

Egypt

Contacts

STUDY_DIRECTORAbeer A.Elhakim El Gendy, PHD, Professor of Endodontics

Ainshams university

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 7, 2026